» Articles » PMID: 29338081

Nonsurgical Premature Menopause and Reproductive Implications in Survivors of Childhood Cancer: A Report from the Childhood Cancer Survivor Study

Overview
Journal Cancer
Publisher Wiley
Specialty Oncology
Date 2018 Jan 17
PMID 29338081
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Survivors of childhood cancer are at risk of nonsurgical premature menopause (NSPM). To the authors' knowledge, risk factors for NSPM and its impact on reproduction remain poorly defined.

Methods: The menopausal status of 2930 survivors diagnosed between 1970 and 1986 (median age, 6 years [range, birth-20 years]) who were aged > 18 years at the time of the current study (median age, 35 years [range, 18-58 years]) was compared with 1399 siblings. NSPM was defined as the cessation of menses ≥6 months in duration occurring 5 years after diagnosis and before age 40 that was not due to pregnancy, surgery, or medications. Among survivors, multivariable logistic regression identified risk factors for NSPM. Pregnancy and live birth rates were compared between survivors with and without NSPM.

Results: A total of 110 survivors developed NSPM (median age, 32 years [range, 16-40 years]), with a prevalence at age 40 years of 9.1% (95% confidence interval [95% CI], 4.9%-17.2%); the odds ratio (OR) was 10.5 (95% CI, 4.2-26.3) compared with siblings. Independent risk factors included exposure to a procarbazine dose ≥4000 mg/m (OR, 8.96 [95% CI, 5.02-16.00]), any dose of ovarian radiation (OvRT) (OvRT < 500 cGy: OR, 2.73 [95% CI, 1.33-5.61] and OvRT ≥ 500 cGy: OR, 8.02 [95% CI, 2.81-22.85]; referent RT, 0), and receipt of a stem cell transplantation (OR, 6.35; 95% CI, 1.19-33.93). Compared with survivors without NSPM, those who developed NSPM were less likely to ever be pregnant (rate ratio, 0.49; 95% CI, 0.27-0.80) or to have a live birth (rate ratio, 0.42; 95% CI, 0.19-0.79) between ages 31 and 40 years.

Conclusions: Survivors of childhood cancer are at risk of NSPM associated with lower rates of live birth in their 30s. Those at risk should consider fertility preservation if they anticipate delaying childbearing. Cancer 2018;124:1044-52. © 2018 American Cancer Society.

Citing Articles

Fertility assessment in long-term young female survivors with hematological disease after allogeneic hematopoietic cell transplantation: a single-center real-life cross-sectional study.

Hou Y, Li Z, Bai L, Li S, Ai J, Cheng C Ann Hematol. 2025; .

PMID: 40014081 DOI: 10.1007/s00277-025-06275-4.


Ovarian function in adolescents and young adults undergoing cancer treatment: biochemical and ultrasound marker analysis.

Signorino C, Bencini E, Tondo A, Scalini P, Tamburini A, Casini T Endocr Connect. 2025; 14(4).

PMID: 39887687 PMC: 11896650. DOI: 10.1530/EC-24-0511.


Galaxamide alleviates cisplatin-induced premature ovarian insufficiency via the PI3K signaling pathway in HeLa tumor-bearing mice.

Tao H, Chen Z, Yao B, Ren X, Shuai H, Xu S BMC Cancer. 2024; 24(1):1060.

PMID: 39192214 PMC: 11350984. DOI: 10.1186/s12885-024-12848-9.


Anti-Müllerian hormone and fertility in women after childhood cancer treatment: Association with current infertility risk classifications.

Nystrom A, Morse H, Ora I, Henic E, Engellau J, Wieslander E PLoS One. 2024; 19(8):e0308827.

PMID: 39133666 PMC: 11318921. DOI: 10.1371/journal.pone.0308827.


Icariin alleviates cisplatin-induced premature ovarian failure by inhibiting ferroptosis through activation of the Nrf2/ARE pathway.

Li F, Zhu F, Wang S, Hu H, Zhang D, He Z Sci Rep. 2024; 14(1):17318.

PMID: 39068256 PMC: 11283570. DOI: 10.1038/s41598-024-67557-x.


References
1.
Wallace W, Thomson A, Saran F, Kelsey T . Predicting age of ovarian failure after radiation to a field that includes the ovaries. Int J Radiat Oncol Biol Phys. 2005; 62(3):738-44. DOI: 10.1016/j.ijrobp.2004.11.038. View

2.
Leisenring W, Mertens A, Armstrong G, Stovall M, Neglia J, Lanctot J . Pediatric cancer survivorship research: experience of the Childhood Cancer Survivor Study. J Clin Oncol. 2009; 27(14):2319-27. PMC: 2738644. DOI: 10.1200/JCO.2008.21.1813. View

3.
Thomas-Teinturier C, El Fayech C, Oberlin O, Pacquement H, Haddy N, Labbe M . Age at menopause and its influencing factors in a cohort of survivors of childhood cancer: earlier but rarely premature. Hum Reprod. 2012; 28(2):488-95. DOI: 10.1093/humrep/des391. View

4.
Wallace W, Anderson R, Irvine D . Fertility preservation for young patients with cancer: who is at risk and what can be offered?. Lancet Oncol. 2005; 6(4):209-18. DOI: 10.1016/S1470-2045(05)70092-9. View

5.
Borgmann-Staudt A, Rendtorff R, Reinmuth S, Hohmann C, Keil T, Schuster F . Fertility after allogeneic haematopoietic stem cell transplantation in childhood and adolescence. Bone Marrow Transplant. 2011; 47(2):271-6. DOI: 10.1038/bmt.2011.78. View